Effect of telomerase inhibition on telomerase activity, telomere length and growth properties of human tumor cell lines
Bisoffi, M.; Stephens, N.D.; Chakerian, A.E.; Fore, M.L.; Bryant, J.E.; Moyzis, R.K.; Griffith, J.K.
Cancer Gene Therapy 3(6 CONF Suppl ): S37
1996
ISSN/ISBN: 0929-1903 Accession: 031117086
PDF emailed within 1 workday: $29.90
Related References
Dratwa, M.; Wysoczanska, B.; Turlej, E.; Anisiewicz, A.; Maciejewska, M.; Wietrzyk, J.; Bogunia-Kubik, K. 2020: Heterogeneity of telomerase reverse transcriptase mutation and expression, telomerase activity and telomere length across human cancer cell lines cultured in vitro Experimental Cell Research 396(1): 112298Delhommeau, Fçois.; Thierry, A.; Feneux, Dèle.; Lauret, E.; Leclercq, E.; Courtier, M.Hélène.; Sainteny, Fçoise.; Vainchenker, W.; Bennaceur-Griscelli, A. 2002: Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant Oncogene 21(54): 8262-8271
Savre-Train, I.; Gollahon, L.S.; Holt, S.E. 2008: Clonal Heterogeneity in Telomerase Activity and Telomere Length in Tumor-Derived Cell Lines Proceedings of the Society for Experimental Biology and Medicine 223(4): 379-388
Savre-Train, I.; Gollahon, L.S.; Holt, S.E. 2000: Clonal heterogeneity in telomerase activity and telomere length in tumor-derived cell lines Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 223(4): 379-388
Asai, A.; Kiyozuka, Y.; Yoshida, R.; Fujii, T.; Hioki, K.; Tsubura, A. 1998: Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs Anticancer Research 18(3a): 1465-1472
Nishio, Y.; Nakanishi, K.; Ozeki, Y.; Jiang, S.-X.; Kameya, T.; Hebisawa, A.; Mukai, M.; Travis, W.D.; Franks, T.J.; Kawai, T. 2007: Telomere length, telomerase activity, and expressions of human telomerase mRNA component (hTERC) and human telomerase reverse transcriptase (hTERT) mRNA in pulmonary neuroendocrine tumors Japanese Journal of Clinical Oncology 37(1): 16-22
Kiyozuka, Y.; Asai, A.; Senzaki, H.; Uemura, Y.; Nakashima, A.; Morimoto, J.; Matsuzawa, A.; Tsubura, A. 1998: Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression International Journal of Molecular Medicine 2(4): 437-444
Morita, M.; Nakanishi, K.; Kawai, T.; Fujikawa, K. 2004: Telomere length, telomerase activity, and expression of human telomerase reverse transcriptase mRNA in growth plate of epiphyseal articular cartilage in femoral head during normal human development and in thanatophoric dysplasia Human Pathology 35(4): 403-411
Strahl, C.; Blackburn, E.H. 1996: Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines Molecular and Cellular Biology 16(1): 53-65
Morii, K.; Tanaka, R.; Onda, K.; Tsumanuma, I.; Yoshimura, J. 1997: Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas Biochemical and Biophysical Research Communications 239(3): 830-834
Avilion, A.A.; Piatyszek, M.A.; Gupta, J.; Shay, J.W.; Bacchetti, S.; Greider, C.W. 1996: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues Cancer Research 56(3): 645-650
Tsutsui, T.; Sekiguchi, M.; Kumakura, S.; Tamura, Y.; Barrett, J.C. 1998: Variability in telomere length and genomic instability in immortal human cell lines with undetectable levels of telomerase activity Proceedings of the American Association for Cancer Research Annual Meeting 39: 567
Villa, R.; Folini, M.; Perego, P.; Supino, R.; Setti, E.; Daidone, M.G.; Zunino, F.; Zaffaroni, N. 2000: Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents International Journal of Oncology 16(5): 995-1002
Kiyozuka, Y.; Yamamoto, D.; Yang, J.; Uemura, Y.; Senzaki, H.; Adachi, S.; Tsubura, A. 2000: Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells Anticancer Research 20(1a): 203-212
Park, K.H.; Rha, S.Y.; Kim, C.H.; Kim, T.S.; Yoo, N.C.; Kim, J.H.; Roh, J.K.; Noh, S.H.; Min, J.S.; Lee, K.S.; Kim, B.S.; Chung, H.C. 1998: Telomerase activity and telomere lengths in various cell lines: changes of telomerase activity can be another method for chemosensitivity evaluation International Journal of Oncology 13(3): 489-495
Ramachandran, C.; Fonseca, H.B.; Jhabvala, P.; Melnick, S.J.; Escalon, E. 2001: Inhibition of Human Telomerase Reverse Transcritpase (hTERT) and Telomerase Activity by Curcumin in Human Mammary Epithelial and Breast Carcinoma Cell Lines Thescientificworldjournal 1: 109
Saini, N.; Srinivasan, R.; Chawla, Y.; Sharma, S.; Chakraborti, A.; Rajwanshi, A. 2009: Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status Liver International: Official Journal of the International Association for the Study of the Liver 29(8): 1162-1170
Kageyama, Y.; Kamata, S.; Yonese, J.; Oshima, H. 1997: Telomere length and telomerase activity in bladder and prostate cancer cell lines International Journal of Urology: Official Journal of the Japanese Urological Association 4(4): 407-410
Imai, S.; Kiyozuka, Y.; Tsubura, A. 1997: Telomerase, telomere length and telomerase RNA expression in the progression of mouse mammary tumor Tumor Biology 18(Suppl 2): 120
Fehrer, C.; Voglauer, R.; Wieser, M.; Pfister, G.; Brunauer, R.; Cioca, D.; Grubeck-Loebenstein, B.; Lepperdinger, G.ün. 2006: Techniques in gerontology: cell lines as standards for telomere length and telomerase activity assessment Experimental Gerontology 41(6): 648-651